#Sushanta Sarkar

Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy

胃癌基础与临床转化研究实验室 , 中国科学院

Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action

胃癌基础与临床转化研究实验室 , 中国科学院

Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis

胃癌基础与临床转化研究实验室 , 中国科学院

RYBP predicts survival of patients with non-small cell lung cancer and regulates tumor cell growth and the response to chemotherapy

胃癌基础与临床转化研究实验室 , 中国科学院

LabXing 上可以免费创建课题组网站